“Our findings reinforce the importance of RSV vaccination in older adults and suggest that monitoring for signs of heart ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, ...

Despite near universal availability of nirsevimab, only 35% of eligible children receive nirsevimab for RSV prophylaxis.

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Winter is here, and with it come higher rates of respiratory illnesses. If you've been struck down recently with a sore ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

GSK is taking to the airwaves to get the message out about respiratory syncytial virus (RSV), presenting a TV special about how the pathogen has affected athletes in the upcoming National Senior Games ...

An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...